Dubai:The UAE has become the first country in the world to approve an innovative oral treatment for vitiligo, as announced during the 10th Conference of the Dermatology Division of the Emirates Medical Association. The event, held at the InterContinental Dubai - Festival City, gathers over 500 physicians and specialists globally to discuss the latest advancements in dermatology.
According to Wam, the conference, presided over by Dr. Ayman Alnaeem, President of the Emirates Dermatology Society, aims to enhance knowledge exchange and advance medical practice through a specialized scientific platform. Dr. Alnaeem emphasized the event’s role in strengthening collaboration among specialists and sharing leading scientific research findings.
The conference includes a diverse scientific program with advanced lectures, workshops, live demonstrations, and interactive sessions on clinical cases. It features discussions on topics such as skin aging, eczema, acne, skin cancer, and inflammatory skin diseases, with a focus on innovations in dermatology and new therapeutic approaches.
Dr. Alnaeem highlighted that the approval and launch of the vitiligo treatment is a landmark event, reflecting the UAE's leadership in pharmaceutical innovations. The conference will also see the launch of new dermatology therapies, including advanced biological treatments for psoriasis, underscoring the UAE's position as a hub for medical innovation.
Dr. Jawaher Al Naqbi, Head of Dubai's Bid to Host the World Congress of Dermatology, discussed Dubai's official bid to host the event in 2031. She noted the city's strong chances due to its infrastructure and global standing, with competing cities including Madrid, Istanbul, and Cairo. Dr. Al Naqbi emphasized Dubai's development journey and achievements in the health sector as key factors in its bid.
Source Wam